Tech Company Financing Transactions

Omicia Funding Round

Omicia closed a $23 million Series B funding round on 6/8/2016. Backers included Acadia Woods Ventures, ARTIS Ventures and Buchanan Ventures.

Transaction Overview

Company Name
Announced On
6/8/2016
Transaction Type
Venture Equity
Amount
$23,000,000
Round
Series B
Proceeds Purpose
Omicia's latest financing will be used to fuel acceleration in product development and an expansion in sales, sales support, marketing and operations. In addition, the company plans to extend variations of its flagship OpalTM Clinical platform for use in new geographies and new verticals including life science research, clinical trial support, population health management and consumer applications.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1625 Clay St. 2nd Floor
Oakland, CA 94612
USA
Email Address
Overview
Omicia is unlocking the potential of personalized medicine. Our mission is to help researchers and clinicians understand and apply the most relevant information from personal genome sequences, to improve disease management and medical outcomes.
Profile
Omicia LinkedIn Company Profile
Social Media
Omicia Company Twitter Account
Company News
Omicia News
Facebook
Omicia on Facebook
YouTube
Omicia on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Matt Tindall
  Matt Tindall LinkedIn Profile  Matt Tindall Twitter Account  Matt Tindall News  Matt Tindall on Facebook
Chief Medical Officer
Paul Billings
  Paul Billings LinkedIn Profile  Paul Billings Twitter Account  Paul Billings News  Paul Billings on Facebook
Chief Operating Officer
Adam Grant
  Adam Grant LinkedIn Profile  Adam Grant Twitter Account  Adam Grant News  Adam Grant on Facebook
Chief Scientific Officer
Martin Reese
  Martin Reese LinkedIn Profile  Martin Reese Twitter Account  Martin Reese News  Martin Reese on Facebook
Chief Technical Officer
Edward Kiruluta
  Edward Kiruluta LinkedIn Profile  Edward Kiruluta Twitter Account  Edward Kiruluta News  Edward Kiruluta on Facebook
VP - Product Management
Charlene Rigby
  Charlene Rigby LinkedIn Profile  Charlene Rigby Twitter Account  Charlene Rigby News  Charlene Rigby on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/8/2016: Amplitude venture capital transaction
Next: 6/8/2016: RetraceHealth venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We do our best to report on all VC transactions involving tech companies. All VC database entries reported here come from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary